Prostate Cancer - Results from #22080

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer - Abstract October 9, 2013

Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: Surgical, oncological and short-term functional outcomes - Abstract October 9, 2013

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer - Abstract October 9, 2013

Intraductal carcinoma of prostate: A comprehensive and concise review - Abstract October 9, 2013

A new era of testosterone and prostate cancer: From physiology to clinical implications - Abstract October 9, 2013

Effect of repeated prostate biopsies on erectile function in men under active surveillance for prostate cancer - Abstract October 9, 2013

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: Toxicity and matched case comparison with postoperative prostate bed-only radiotherapy - Abstract October 9, 2013

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: Early late toxicity and 3-year clinical outcome - Abstract October 9, 2013

The role of cryosurgery of the prostate for nonsurgical candidates - Abstract October 9, 2013

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance - Abstract October 9, 2013

The use of an active appearance model for automated prostate segmentation in magnetic resonance - Abstract October 8, 2013

Ten-year outcomes of sexual function after radical prostatectomy: Results of a prospective longitudinal study - Abstract October 8, 2013

Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: Identifying candidates for early salvage therapy - Abstract October 8, 2013

A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer - Abstract October 8, 2013

Biochemical and objective response to abiraterone acetate withdrawal: Incidence and clinical relevance of a new scenario for castration-resistant prostate cancer - Abstract October 8, 2013

Co-existent Paget's disease of the bone, prostate carcinoma skeletal metastases and fracture on skeletal scintigraphy-lessons to be learned - Abstract October 8, 2013

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer - Abstract October 8, 2013

Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era - Abstract October 8, 2013

3D prostate histology reconstruction: An evaluation of image-based and fiducial-based algorithms - Abstract October 8, 2013

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: Interim analysis of acute toxicity and quality of life in 124 patients - Abstract October 8, 2013

Page 1105 of 1435